Company Description
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States.
The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders.
The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors.
Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Country | United States |
IPO Date | Jun 12, 2017 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 101 |
CEO | Paul R. Gudonis |
Contact Details
Address: 137 Portland Street Boston, Massachusetts United States | |
Website | https://www.myomo.com |
Stock Details
Ticker Symbol | MYO |
Exchange | AMEX |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001369290 |
CUSIP Number | 62857J201 |
ISIN Number | US62857J2015 |
Employer ID | 00-0000000 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Paul R. Gudonis | Chairman, President & Chief Executive Officer |
David A. Henry | Chief Financial Officer |
Colin Anderson | Global Director of Operations |
Dr. Harry Kovelman M.D. | Chief Medical Officer |
Galina Shtivelman | Senior Director of Human Resources |
Joseph Chicoskie | Director of Marketing |
Micah J. Mitchell | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 05, 2024 | 8-K | Current Report |
Dec 05, 2024 | 424B5 | Filing |
Dec 04, 2024 | 424B5 | Filing |
Nov 06, 2024 | 10-Q | Quarterly Report |
Nov 06, 2024 | 8-K | Current Report |
Nov 05, 2024 | 4 | Filing |
Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Oct 04, 2024 | 4 | Filing |
Sep 09, 2024 | 4 | Filing |
Sep 05, 2024 | 4 | Filing |